Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Statistical Methods in Medical Research|March 31, 2026
Eliminating residual confounding in the stratified estimator via smoothing along with the propensity scoreNaoto Tsujimoto, Satoshi Hattori
Diabetes, Obesity & Metabolism|November 15, 2021
Utilization of glucagon-like peptide-1 receptor agonists and changes in clinical characteristics in patients with type 2 diabetes by chronic kidney disease stage in Japan: A descriptive observational study using a nationwide electronic medical records databaseNaoki Hirose, Naoto Tsujimoto, Taeko Katayose, et al.
Modern Rheumatology|March 21, 2026
Patient-Reported Outcomes in Patients with Rheumatoid Arthritis Treated with Baricitinib: A Prospective Observational Study in JapanYuko Kaneko, Naoto Tsujimoto, Izumi Sato, et al.
Modern Rheumatology|November 22, 2025
Retention of baricitinib-treated patients with rheumatoid arthritis in Japan: Interim results from a prospective observational cohort studyYuko Kaneko, Chaochen Wang, Naoto Tsujimoto, et al.
Pragmatic and Observational Research|May 23, 2020
Real-World Safety and Effectiveness of Tadalafil in Patients with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Japanese Post-Marketing Surveillance StudyHiroyoshi Yamazaki, Naoto Tsujimoto, Momoha Koyanagi, et al.
Nature Communications|February 14, 2019
Ferromagnetism above 1000 K in a highly cation-ordered double-perovskite insulator Sr<sub>3</sub>OsO<sub>6</sub>Yuki K Wakabayashi, Yoshiharu Krockenberger, Naoto Tsujimoto, et al.
Annals of Clinical Epidemiology|March 20, 2024
Validation Study of Algorithms to Identify Malignant Tumors and Serious Infections in a Japanese Administrative Healthcare DatabaseAtsushi Nishikawa, Eiko Yoshinaga, Masaki Nakamura, et al.
Cancer Medicine|September 9, 2021
Merestinib monotherapy or in combination for japanese patients with advanced and/or metastatic cancer: A phase 1 studyToshihiko Doi, Noboru Yamamoto, Yoichi Naito, et al.
Advances in Therapy|November 9, 2024
Comparative Effectiveness of Biologic Classes in Clinical Practice: Month 12 Outcomes from the International Observational Psoriasis Study of Health Outcomes (PSoHO)Saakshi Khattri, Álvaro González-Cantero, Burhan Engin, et al.
Modern Rheumatology|August 6, 2022
Safety and effectiveness of baricitinib for rheumatoid arthritis in Japanese clinical practice: 24-week results of all-case post-marketing surveillanceMichiaki Takagi, Tatsuya Atsumi, Hiroaki Matsuno, et al.
Pageof 2